Post hoc analysis of LASTE in 181 patients with ASPECTS 0–2 stroke: thrombectomy plus medical care improved 90-day mRS (generalised OR 1.81) and lowered mortality (38.4% vs 59.6%) vs medical care alone; symptomatic ICH 12.9% vs 4.5% (not significant).
Secondary analysisn = 181
Lapergue et al. Endovascular Thrombectomy in Patients With Largest Baseline Infarcts (ASPECTS 0-2): An Ancillary Analysis of the LASTE Trial